MDC Associates, a premier regulatory and clinical consulting firm specializing in in vitro diagnostics (IVDs) and medical devices, will attend ADLM 2025—the leading laboratory medicine conference ...

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and ...

Global Cystatin C Assay Market is valued at approximately USD 350.70 million in 2022 and is anticipated to grow with a healthy growth rate of more than 7.5% during the forecast period 2023-2030. Read ...

A free webinar has encouraged medical device innovators to learn more about new Post-Market Surveillance (PMS) legislation ...

The company plans to bring to market in the coming years a series of microarray-based tests for autoimmune diseases and allergies, among other tests.

Learn how in vitro diagnostic (IVD) devices can comply with IVDR and Indian MDR standards, ensuring regulatory alignment, ...

Revolutionary Platform Sets New Benchmark for Transparency and Compliance in Diagnostic AI As the May 26th CE-IVDR compliance deadline comes into effect, Diagnostics.ai launches the industry’s ...

On 6 June 2025, the European Commission launched a targeted stakeholder consultation on the classification and regulation of ...

A free-to-join webinar taking place at the end of June will encourage medical device innovators to learn more about new ...

A free to join webinar will encourage medical device innovators to learn more about new post-market surveillance legislation.

Invivoscribe's subsidiary, LabPMM, has secured New York State (NYS) approval for the NPM1 MRD Assay to combat acute myeloid ...